Armephaco JSC

Armephaco JSC EPS Growth

The EPS Growth of Armephaco JSC (AMP.VN) as of Nov 2, 2026 is 9.70 %. In the previous year, EPS Growth was 0.91 % — a change of 970.11% (higher).

EPS Growth

9.70 %

YoY

970.11%

Last updated:

EPS Growth of Armephaco JSC is 2025 9.70 % . EPS Growth of Armephaco JSC was 2024 0.91 % . It decreases by 970.11% higher compared to the previous year.

The Armephaco JSC EPS Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS Growth
Date
EPS Growth
Jan 1, 2018
-68.24 VND
Jan 1, 2019
14.89 VND
Jan 1, 2020
-19.18 VND
Jan 1, 2021
-6.41 VND
Jan 1, 2022
-28.29 VND
Jan 1, 2023
-4.03 VND
Jan 1, 2024
0.91 VND
Jan 1, 2025
9.70 VND
The Armephaco JSC EPS Growth history
YEAREPS GrowthYoY
9.70 %+970.11%
0.91 %-122.51%
-4.03 %-85.76%
-28.29 %+341.39%
-6.41 %-66.58%
-19.18 %-228.85%
14.89 %-121.81%
-68.24 %-2,993.69%
2.36 %-93.41%
35.78 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Armephaco JSC Stock analysis

What does Armephaco JSC do? Armephaco JSC manufactures pharmaceutical and medical equipment products, focusing on glucose meters, sphygmomanometers, beds, medical exam tables, stools, and syringe destroyers. The company distributes medical devices and equipment through its manufacturing and distribution channels, targeting healthcare providers and hospitals. It also produces and trades diversified medicines, including antibiotics, vitamins, pain relievers, antipyretics, gastrointestinal, and anti-allergic drugs, serving the broader healthcare market. The firm generates revenue from the sale of medical devices and equipment, as well as from pharmaceutical products. Healthcare providers and hospitals purchase the medical devices and equipment, while the diversified medicines are sold to pharmacies and healthcare institutions. Armephaco JSC's product portfolio includes glucose meters, sphygmomanometers, beds, medical exam tables, stools, syringe destroyers, antibiotics, vitamins, pain relievers, antipyretics, gastrointestinal, and anti-allergic drugs. Armephaco JSC's business model centers on the production and distribution of medical devices and pharmaceuticals. The company's primary customers are healthcare providers, hospitals, pharmacies, and healthcare institutions. The revenue streams are derived from the direct sale of medical equipment and pharmaceutical products to these segments, with no mention of additional services or partnerships. Armephaco JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Armephaco JSC stock

EPS Growth of Armephaco JSC is 9.70 % in 2025.

On Eulerpool you can find the complete historical development of EPS Growth Armephaco JSC since 2006 – with annual values, charts, and detailed analysis.

EPS growth measures the percentage change in earnings per share. It accounts for both profit changes and share count changes.

To evaluate EPS Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EPS Growth.

EPS Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EPS Growth's Armephaco JSC historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Armephaco JSC

All Key Metrics — Armephaco JSC